HEATHER MOISER: Open Payments
NPI 1457790974 · ARDMORE, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$840 in 50 payments from 11 companies in 2025. Trend: 2023 $56 · 2024 $390 · 2025 $840
Food & beverage: $840
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $197 |
| AstraZeneca Pharmaceuticals LP | 9 | $196 |
| Lilly USA, LLC | 12 | $168 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $61 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $47 |
| Phathom Pharmaceuticals, Inc. | 5 | $45 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $32 |
| ABBVIE INC. | 1 | $20 |
| Averitas Pharma Inc. | 1 | $17 |
Products named: MOUNJARO, FARXIGA, Rybelsus, BREZTRI, Ozempic, Kerendia, Saxenda, CAPLYTA.
Industry payments across OK — which companies pay providers there.
